M&A advisors: "We've never seen such investor interest in this service before"

Nordic healthcare companies are sought after by specialized private equity funds, with one particular segment having around 30 annual Nordic trades has garnered a lot of interest and sky-high valuations.
Nordic M&A Managing Partner Managing Partner Anders W. Eriknauer. | Photo: PR
Nordic M&A Managing Partner Managing Partner Anders W. Eriknauer. | Photo: PR
BY OLE ANDERSEN, KAPITALWATCH

Denmark and Sweden have started to resemble battle grounds for global and highly specialized healthcare investors competing for the most attractive Nordic biotech and life science companies in the steadily growing markets of the future.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading